Targeted Lipid Delivery for Nucleic Acid Localization
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current lipid-based delivery systems for nucleic acids and proteins lack targeted delivery mechanisms, often failing to localize the therapeutic cargo effectively to specific cells, tissues, or organs.
Innovation Solution
Development of new lipids and a tropism discovery platform for screening and developing targeting systems that enable localized delivery of nucleic acid and protein therapeutics, specifically to immune cells.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current lipid-based delivery systems are used to protect nucleic acid cargo, then the therapeutic cargo is protected from degradation, but the delivery system fails to localize the therapeutic cargo effectively to specific cells, tissues, or organs
Solution Approach 1:
The patent applies local quality by modifying the lipid delivery system with specific targeting moieties (such as antibodies, protein conjugates, or ligands) that are selectively expressed or bind to specific cell types, tissues, or organs. This creates heterogeneity in the delivery system where certain lipids are equipped with targeting capabilities while others remain general-purpose, allowing the system to achieve both broad protection and specific localization as needed.
Solution Approach 2:
The patent employs composite materials by combining traditional lipid components with various targeting moieties, conjugates, or functional groups to create hybrid lipid structures. These composite lipids integrate the protective properties of conventional lipids with the targeting capabilities of attached molecules, enabling simultaneous cargo protection and localized delivery to specific biological targets.
2Ease of manufacture
If lipid-based delivery systems are designed for broad protection, then the delivery system is simple and easy to manufacture, but the therapeutic cargo cannot be delivered to the intended cellular or tissue site with high specificity
Solution Approach 1:
The patent applies segmentation by dividing the lipid delivery system into distinct functional modules: core lipid components that provide protection and simplicity, and separate targeting moieties that provide specificity. This modular approach allows the core lipid structure to remain easy to manufacture while the targeting components can be selectively added or conjugated to achieve the desired delivery precision without complicating the entire system.
Solution Approach 2:
The patent uses intermediary elements such as conjugates, linkers, or fusion proteins that bridge the gap between the simple lipid structure and the complex targeting requirement. These intermediaries can be attached to the lipid surface and provide the necessary specificity for targeted delivery while maintaining the overall simplicity and ease of manufacture of the base lipid system.
3Adaptability or versatility
If existing lipid delivery systems are used, then the system is well-established and easy to implement, but it cannot achieve high efficacy and specificity for localized delivery to immune cells or specific tissues
Solution Approach 1:
The patent applies universality by designing a platform approach where a core lipid system can be adapted for multiple functions by attaching different targeting moieties. The same basic lipid structure can be used for delivering cargo to different cell types, tissues, or organs by simply changing the conjugated targeting component, thereby maintaining broad applicability while achieving high delivery efficacy for each specific indication.
Solution Approach 2:
The patent employs dynamics by creating a flexible and adaptable lipid delivery system where the targeting moieties can be dynamically adjusted or selected based on the specific therapeutic indication. This dynamic capability allows the system to transition from a static, fixed-function delivery system to a flexible platform that can be optimized for different targets and indications, enhancing both versatility and reliability.
Data Source
AI summary
The present disclosure details various lipids, compositions, and/or methods of optimized systems and delivery vehicles for the delivery of nucleic acid sequences, polypeptides or peptides for use in vaccinating against infectious agents.